DENTSPLY SIRONA Inc.

DENTSPLY SIRONA Inc. announced it will host an investor conference call and live webcast on Thursday, November 5, 2026, at 4:30 p.m. EST to discuss its third quarter 2026 financial results. The company will make financial earnings materials available on its investor website prior to the call, and a webcast replay will also be accessible afterward.

Dentsply Sirona reported second quarter 2026 financial results, with net sales decreasing 4.1% to $898 million. The company achieved a GAAP diluted EPS of $0.18, a significant improvement from a loss of $0.22 in the prior year, while adjusted EPS remained flat at $0.52. Dentsply Sirona also announced an expanded partnership with Medline Sinclair and repurchased 1.3 million shares, while reiterating its full-year 2026 outlook for net sales and adjusted EPS.

Dentsply Sirona reported a net income of $37 million, or $0.18 diluted EPS, for the second quarter of 2026, a significant improvement from a net loss of $45 million, or $(0.22) diluted EPS, in the prior year. Net sales for the quarter decreased to $898 million from $936 million. The company incurred $57 million in restructuring charges under the 2026 Plan and repurchased $12 million of common stock.

Dentsply Sirona announced an expansion of its long-standing relationship with Medline Sinclair, a leading Canadian dental distributor. Effective September 1, 2026, Medline Sinclair will begin offering Dentsply Sirona's technology portfolio across Canada, building on a successful relationship that previously focused on consumables. This expansion aims to increase access to Dentsply Sirona's digital dentistry solutions through Medline Sinclair's nationwide network, representing the sixth dealer network enhancement for Dentsply Sirona in North America this year.

Dentsply Sirona and PDS Health announced that PDS Health practices have surpassed five million CEREC chairside restorations, highlighting the extensive adoption and integration of digital restorative workflows. This achievement underscores the long-standing collaboration between the two companies and the benefits of connected digital dentistry, including enhanced efficiency, consistency, and same-day treatment capabilities for patients. PDS Health is noted as one of the highest-volume users of chairside CAD/CAM technology, with over 1,200 CEREC systems installed.

Dentsply Sirona Inc. announced the appointment of John Fortson as Executive Vice President and Chief Financial Officer, effective July 20. Mr. Fortson brings over 25 years of leadership experience in finance, operations, and strategy, including 13 years as a CFO or CEO of global manufacturing and industrial businesses. The company expressed confidence that his experience will be instrumental in advancing its "Return-to-Growth Action Plan" and driving long-term value creation.

Dentsply Sirona announced an expanded partnership with Nashville Dental, Inc. (NDI), a leading independent dental distributor. Effective August 1, 2026, NDI will distribute Dentsply Sirona's full range of connected technology solutions, including the CEREC system and Primescan intraoral scanners, across a nine-state territory in the Southeast and Mid-Atlantic regions. This move aims to strengthen Dentsply Sirona's U.S. distribution footprint, improve customer access to advanced digital dentistry technologies, and drive adoption through trusted local partners.

Dentsply Sirona Inc. announced its participation in the 2026 Stifel Jaws & Paws Conference. The company's management is scheduled to present on May 27, 2026, at 3:35 p.m. ET. Investors can access a live audio webcast and replay through the Investors section of the Dentsply Sirona website.

Dentsply Sirona reported a net loss of $10 million for Q1 2026, a significant decline from a net income of $20 million in Q1 2025, despite flat net sales of $880 million. This loss was primarily driven by a substantial increase in restructuring and other costs, which surged to $67 million from $9 million in the prior year. The company approved a new restructuring plan in February 2026, incurring $60 million in charges by quarter-end.

Dentsply Sirona reported Q1 2026 net sales of $880 million, a slight increase of 0.1% year-over-year. The company posted a GAAP net loss per share of ($0.05) and adjusted EPS of $0.27, down 39.0% from the prior year. Despite near-term pressures, Dentsply Sirona launched its AI-enabled diagnostic aid, Smart View-Detect, expanded distribution agreements, and began implementing a new capital allocation strategy. The company reiterated its full-year 2026 outlook for net sales and adjusted EPS.